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ABSTRACT
Background: Percentage of patients who had liver stiffness measurement failure using transient elastography 
???????????????????????????????????????????????????????????????????????????????????????????????????????????
stiffness measurement in patients with obesity. The objective of this study is to evaluate the success of liver 
???????????????????????????? ??????????????????????????????????????????
Method: ???????????????????????????????????????????????????????????????????????????????????????????????????
then analysed using statistical analysis unpaired t-test or Mann-Whitney and McNemar statistical tests.
Results: From 92 non-alcoholic fatty liver (NAFLD) patients with obesity who were studied, the proportion of 
??????????? ??????????????????????????????? ??????? ?????????? ????????????? ???????? ??????????????????????????
????????????????????????????? ??????????????????????? ?????????????????? ??? ??????????????????????????????????
thoracic circumference were associated with success in measuring liver stiffness using M probe, with p value 
of 0.007, 0.001, and 0.001 respectively. The results of Mann-Whitney statistical test revealed median value of 
BMI and SCD of patients who had liver stiffness measurement failure using M probe were 32.7 kg/m2 and 2.6 
cm respectively. T-test results showed that the mean value of thoracic circumference of patients who had liver 
stiffness measurement failure using M probe was 97.8 cm. 
Conclusion: ????????????????????????? ???????????????????????????? ?????????????? ?????????????????? ????????
was better compared to the M probe. BMI, SCD, and thoracic circumference were associated with the success 
??????????????????????????????????? ?????????????????????????????????????????????????????????????
Keywords:????????????????????????? ?????????????????????????
ABSTRAK
Latar belakang: Persentase pasien yang gagal dalam pengukuran kekakuan hati menggunakan transient 
????????????? ??????????? ??????? ??????? ??????? ??????????? ????? ???????????????????? ??????????? ??????
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meningkatkan keberhasilan pengukuran kekakuan hati pada pasien dengan obesitas. Tujuan penelitian ini 
adalah untuk menilai keberhasilan pengukuran kekakuan hati dengan menggunakan probe M ?????????????
faktor yang mempengaruhinya.
Metode: Pasien yang memenuhi kriteria inklusi diikutsertakan dalam penelitian ini. Hasil pemeriksaan kemudian 
dianalisis dengan menggunakan uji statistic unpaired t-test atau Mann-Whitney dan uji statistik McNemar.
Hasil: Dari 92 pasien penyakit perlemakan hati non-alkohol dengan obesitas yang diteliti, Proporsi 
???????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????
capsule distance (SCD), dan lingkar toraks berhubungan dengan keberhasilan pengukuran kekakuan hati dengan 
menggunakan probe M, dengan nilai p masing-masing 0,007,0,001 dan 0,001. Hasil uji statistik Mann-Whitney 
didapatkan nilai median dari IMT dan SCD yang tidak berhasil dilakukan pengukuran kekakuan hati dengan 
menggunakan probe M adalah masing-masing 32,7 kg/m2 dan 2,6 cm. Hasil uji statistik T-test didapatkan nilai 
Mean dari lingkar toraks yang tidak berhasil dengan pengukuran kekakuan hati dengan menggunakan probe 
M adalah 97,8 cm. 
Simpulan: Proporsi keberhasilan pengukuran kekakuan hati pada pasien NAFLD dengan obesitas dengan 
????????????????????? ?????? ????? ???????????????????????????????????? ????? ???????????????????????
berhubungan dengan keberhasilan pengukuran kekakuan hati dengan menggunakanan probe M. Variabel yang 
???????????????????????????????????????
Kata kunci: ?????????????????????????????? ????????????????????
INTRODUCTION
Non–alcoholic fatty liver disease (NAFLD) is one 
of the chronic liver diseases commonly found in the 
world. NAFLD is strongly associated with metabolic 
syndrome, including insulin resistance, diabetes, 
dyslipidaemia, and obesity. NAFLD may develop into 
liver cirrhosis and hepatoma. Prevalence of NAFLD is 
quite high in individuals with obesity, type 2 diabetes 
mellitus, and dyslipidaemia. NAFLD occurs in 60-
95% obese patients, 28-55% type 2 diabetes mellitus 
patients, and 27-92% dyslipidaemia patients.1 Liver 
biopsy remains a gold standard in determining the 
degree of NAFLD. However, liver biopsy frequently 
could not be performed in NAFLD patients due to some 
factors, such as: high cost, bleeding risk, and there is 
still no consensus to determine the histopathological 
criteria of NASH and differences in the degree of 
NAFLD. Currently, there are many modalities which 
can be used to detect the presence of steatosis. 
Liver fibrosis can be evaluated non-invasively 
based on biological and physical approach. Biological 
approach means that by measuring biological markers 
which are measured from patients’ serum and physical 
approach is performed by measuring the degree of liver 
stiffness by using transient elastography (TE).2-4 TE is 
the most recent non-invasive diagnostic modality to 
??????????????????????????????????????????????????????
(LSM).5-10 TE has high accuracy rate and can detect 
the presence of bridging fibrosis in patients with 
chronic liver disease. TE can also be applied in several 
chronic liver diseases, such as NAFLD, hepatitis 
B, primary biliary cirrhosis, sclerosing cholangitis, 
autoimmune hepatitis, alcoholic steatosis, and 
haemochromatosis.11-16
Liver stiffness measurement using TE is initiated by 
placing ultrasound transducer (probe) in the position 
in line with the vibrator axis. Vibrator will produce 
sound wave with low amplitude and frequency (50 
Hz) which triggered the presence of elastic shear 
wave which later propagates as it traverses the 
underlying tissue. The degree of liver stiffness can be 
obtained from measuring sound wave velocity and its 
??????????????????????????????????????????????????????????
sound wave is propagated. Liver stiffness measurement 
using TE has several advantages compared to other 
modalities. First, TE is a non-invasive examination 
that can be performed quickly and painlessly. Second, 
TE may include tissue volume 100 times as big as 
liver biopsy tissue sample, thus it can picture the liver 
????????????????????? ???????????????? ??????????????
???????????????????????????????????????????????????????
by extrahepatic abnormality, thus it does not need 
measurement results adjustments.17 However, not 
all patients can give out liver stiffness measurement 
results using TE, due to the limitations it has. The main 
limitation of TE is associated with the characteristic 
??? ??????????? ????? ?????????????????????? ????? ????
propagation of elastic shear wave may stop before it 
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reaches liver tissue. Therefore, the success of TE will 
decrease in patients with ascites. Additionally, in obese 
patients, the skin to liver capsule distance (SCD) is 
larger; the subcutaneous tissue thickness can cause 
deviation of elastic shear wave before it reaches the 
liver tissue. This can decrease the accuracy and success 
in liver stiffness examination in patients with obesity.18
Currently, new probe has been developed, which 
is XL probe. This new probe has undergone a series 
of clinical tests, which is believed may increase 
the success of liver stiffness measurement (LSM) 
particularly in patients with obesity. XL probe is 
?????????????????????????????????? ????????????????????
lower frequency, larger amplitude of vibration, more 
sensitive transducer, and better depth of underskin 
measurement. A study showed that XL probe could 
increase the validity of measurement results than M 
probe, which was 45% to 76% (p < 0.001).19 Factors 
?????????????????????????? ????????? ???????????????
patient’s age > 50 year old and BMI > 30 kg/m2; while 
??????????????????????????????????????????????????
BMI > 30 kg/m2. However, to diagnose the presence 
??????????????????????????????????????????????????????
difference.20 In the last six months, Hepatology Division 
Cipto Mangunkusumo Hospital found 27 patients who 
experienced failure of LSM from a total of 265 patients 
who underwent the examination. Therefore, the role of 
XL probe is expected to increase the success of LSM, 
although currently there is no study about XL probe in 
Indonesia. Therefore, a study to evaluate the success 
rate of liver stiffness measurement using XL probe in 
patients in Indonesia, particularly in the Division of 
Hepatology Cipto Mangunkusumo Hospital, is needed.
METHOD
The study design being used was cross sectional in 
NAFLD patients with obesity. Study was performed in 
Hepatology Division, Internal Medicine Department 
FMUI/Cipto Mangunkusumo Hospital Jakarta from 
12 March 2013 until 12 June 2013. Target population 
in this study was all NAFLD patients with obesity, 
while accessible population was all NAFLD patients 
with obesity who visited Hepatology Polyclinic Cipto 
Mangunkusumo Hospital. Samples or subjects in this 
study were all NAFLD patients with obesity who 
visited Hepatology Polyclinic, Cipto Mangunkusumo 
Hospital from 12 March 2013 until 12 June 2013. 
??????????????????? ????????? ?????????????? ????????????
obese criteria, which is BMI > 25 kg/m2; (2) Study 
????????? ???????????????????????????????????? ?????
USG results fatty liver was found and from anamnesis 
there was no history of alcohol consumption or alcohol 
consumption not exceeding 70 g/week for female and 
140 g/week for male; (3) Study subjects were willing 
to participate in the study. Exclusion criteria were: (1) 
Presence of ascites from the abdominal USG results; 
(2) Study subjects had skin disease and thus, transient 
elastography was not possible to be performed to 
them; (3) Presence of mass in the chest wall or local 
abnormality in the liver tissue including liver abscess 
or hepatoma.
Sample collection was performed by total sampling, 
?????????????????????????????????????????????????????
criteria in the general subject group in the determined 
period. The minimum sample size was 67 patients. 
Because the same subject received two interventions, 
???????????????????? ??????????????????????? ????
control group was the same group. Therefore, the 
minimum sample size in this study after the additional 
10% for drop outs were 56 patients or was rounded to 60 
patients. All obese patients who visited the Hepatology 
Polyclinic FMUI/Cipto Mangunkusumo Hospital from 
12 March 2013 to 12 June 2013. In a consecutive 
manner, to these patients, several examinations were 
performed, including body weight, body height, body 
mass index, abdominal USG, SCD, and thoracic 
????????????????????????????????????????????????????
examination using M and XL probes. Examination 
was performed to patients on supine position (dorsal 
decubitus) by placing probe on the intercostal space 
that faced the central part of the right lobe of the liver, 
which was 8-10th intercostal space in the axillary line 
by positioning the right arm in the maximal abduction 
position. Probe in the perpendicular position towards 
the skin surface. Examination was considered to be 
successful if there were ten valid measurement results 
with the success rate > 60% and IQR/M < 0.3.
Data collected from this study were then analysed 
and presented in tabular and figure forms. Data 
analyses were performed through analytic descriptive 
using SPSS computer programme version 11.5. To 
compare quantitative data variables between groups, 
unpaired t-test or Mann-Whitney U-test, while to 
compare categorical data variables between groups, 
???????????????????????????????????????????????????????
and absolute test. Fisher’s exact-test was used if data 
did not fulfil the criteria. To compare categorical 
data variables in the same study subjects receiving 
2 different interventions, McNemar statistical test 
was used. Obese patients who visited the Hepatology 
Subdivision FMUI/Cipto Mangunkusumo Hospital 
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consecutively underwent several examinations, 
including antopometric examination (body weight, 
body height, and thoracic circumference) and 
abdominal USG which were then followed with TE 
examination using M and XL probes.
RESULTS
During the period of this study, we obtained 92 
respondents of NAFLD patients with obesity who 
??????????????????????????????????????????????????? ????
performed according to the study pathway. We found 
that there were more female patients (82.6%) compared 
to male (17.4%), average patients’ age 44.3 ± 10.2 
years old. The median value of BMI and SCD were 
31.5 kg/m2 and 2.3 cm, respectively. The mean value 
of thoracic circumference was 94.7 S ± 8.2 cm. These 
data were presented in Table 1.
In concordance with the objectives, in this study, 
we performed examinations towards some factors 
thought to be associated with the success of liver 
stiffness measurement using M and XL probe. Factors 
being studied include BMI, SCD, and thoracic 
circumference. To identify the difference of mean in 
2 groups, we performed t-test statistical test for group 
with normal distribution and Mann-Whitney for group 
with not normal distribution. After normality test 
using Kolmogorov-Sminov was performed, we found 
that thoracic circumference had normal distribution 
and therefore, further analysis was conducted using 
t-test. Meanwhile, because BMI and SCD did not have 
normal distribution, further analysis was performed 
using Mann-Whitney test. The results of this analysis 
could be seen in table 4 for M probe and table 5 for 
XL probe.
Table 1. Respondents’ characteristics
Variables n (%) Mean ± SD Median Range
Sex 
Male 16 (17.4%)
Female 76 (82.6%)
Age 44.3±10.2
???????????????????
Skin to liver 
capsule distance 
(SCD) 2.3 1.4 – 4.3
Thoracic 
circumference 94.7±8.2
Body mass index 
(BMI)
31.5 25.5-54.1
The proportion of success rate in the liver stiffness 
measurement using M probe was 57.6% (53 patients), 
while the proportion of success rate in liver stiffness 
measurement using XL probe was 88% (81 patients). 
This was shown in Table 2.
Table 2. Proportion of liver stiffness measurement 
Liver stiffness measurement n (%)
M probe
Succeed 53 (57.6)
Not succeed 39 (42.4)
XL probe
Succeed 81 (88.0)
Not succeed 11 (12.0)
To know the proportion comparison of the success 
rate in liver stiffness measurement using M and XL 
probes, we performed McNemar statistical test. The 
obtained result was p value < 0.001. This could be 
seen in Table 3.
Table 3. Proportion comparison on the success rate of liver 
stiffness measurement based on probe
M Probe XL Probe p valueSucceed Not succeed
Succeed 51(96.2%) 2 (3.8%) < 0.001Not succeed 30 (76,3%) 9 (23,1%)
Table 4. Factors associated with the success of liver stiffness 
measurement using the M probe
Variables Probe M p valueSucceed Not succeed
Body mass index 30.85 (25.1-41.5) 32.7 (28.2-54.1) 0.007
Skin to liver 
capsule distance 
(SCD)
2.16 (1.4-4.3) 92.4 2.6 (1.7-4.1) 0.001
Thoraric 
circumference
2 (SD 7.3248) 97.8 (SD 8.4) 0.001
From Table 4, it could be seen that BMI, SCD, 
and thoracic circumference were associated with the 
success  of liver stiffness measurement using M probe. 
????????????????????????????????????????????????????????
0.007, 0.001 and 0.001, respectively. The mean value 
of thoracic circumference to which liver stiffness 
measurement was not succeed to be performed using 
the M probe was 97.8 cm. In addition, the median value 
of BMI and SCD to which liver stiffness measurement 
was not succeed to be performed using M probe was 
32.7 kg/m2 and 2.6 cm.
Table 5. Factors associated with the success of liver stiffness 
measurement using the XL probe 
Variables XL Probe p valueSucceed Not succeed 
Body mass index 31.4 (25.1-43.6) 32.5 (28.9-54.1) 0.321
Skin to liver 
capsule distance 
(SCD)
Thoraric 
circumference
2.32 (1.4-4.30)
94.3 (SD 7.6788)
2.5 (1.7-3.8)
97.6 (SD 11.6)
0.817
0.216
From table 5, it could be seen that BMI, SCD, and 
thoracic circumference factors were not associated 
with the success of liver stiffness measurement using 
XL probe with p value of 0.327, 0.817 and 0.216, 
respectively. Based on the data from the available 
study results and for clinical purpose, researcher 
performed further analyses. Factors associated with 
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success of liver stiffness measurement were BMI, SCD, 
and thoracic circumference based on category (BMI 
????????????????????????????????????????????????????
???????????????????????????????????????????? ????????
were performed using Chi-square statistical test which 
results could be seen in Table 6 and 7. 
DISCUSSION
This study is performed to determine the success 
rate of liver stiffness measurement in NAFLD patients 
with obesity in Division of Hepatology, Internal 
Medicine Department Cipto Mangunkusumo Hospital. 
From this study, we obtained 17.4% male patients and 
82.6% female patients. The median value of BMI, SCD, 
and thoracic circumference were 31.53 kg/m2, 2.32 cm 
and 95 cm, respectively. The results of this study were 
different with other studies which have been performed 
by previous researchers. The results of a study by 
Ledinghen et al that studied 99 obese patients reported 
27.2% male patients and 72.8% female patients.16 The 
median value of BMI and SCD were 40.5 kg/m2 and 
2.8 cm. Myers et al studied 276 CLD patients with 
63% of them were male patients.31 The median value 
of BMI, SCD, and thoracic circumference were 30 kg/
m2, 2.20 cm, and 105 cm, respectively.
The percentage of patients whose liver stiffness 
measurement were unreliable using transient 
elastography varied from 2% to 10%, generally caused 
by obesity. In this study, the proportion of failure in 
liver stiffness measurement using M probe was 42.4% 
(39 patient). This could possibly be caused by the obese 
criteria used in this study (BMI > 25), therefore this 
failure was associated with the subcutaneous fat tissue 
and connective tissue thickness which were located 
between the probe and the liver.19,23 In this study, failure 
of liver stiffness measurement using XL probe was 
12% (11 patients). Six from those eleven patients had 
BMI > 30 and 3 patients among them had SCD > 3.5. 
This was in line with the fact that XL probe was 
suggested to be used in SCD > 2.5 cm and < 3.5 cm.18 
Four patients whose measurement failed using the XL 
probe had body height < 150 cm; the failure could be 
associated with the narrow intercostal space. In this 
study, the success of liver stiffness measurement using 
XL probe was higher (88%) compared to the M probe 
???????????????????????????????????????????????????????
This was consistent with the advantage of XL probe 
???????????????????????????????????????????????????
(with lower frequency, higher amplitude, and larger 
depth of measurement), thus could increase the success 
of liver stiffness measurement in obese patients. 
This study obtained the success rate of liver stiffness 
measurement with the proportion of XL probe as 
much as 88% and proportion of M probe was 57.6%. 
Different from previous study by Ledinghen et al who 
studied 99 obese patients with BMI > 30, in which the 
results were success in liver stiffness measurement 
using M probe 45% and 75% in XL probe.16 This could 
possibly happen due to the higher average value of 
BMI and SCD in the study conducted by Ledinghen 
et al compared to the values obtained in this study, 
which were BMI 40.5 kg/m2 and SCD 2.8 cm. The 
results of this study was not of much difference with 
Table 6. Relationship between BMI, SCD, and thoracic circumference based on category 
towards the success rate of liver stiffness measurement using M probe
Variables
M Probe
OR p value
Succeed Not succeed
Body mass index
0.042??????? 26 (72.2%) 10 ( 27.8%)  2.732
>30.85 27.0 (48,2%) 29 (51.8%) (1.138-8.356)
Skin to liver capsule distance
0,003?????? 27 ( 79.4%) 7 (20.8%) 4.742
>2.16 28 (44.82%) 32 (55.2%) (1.783-12.639)
Thoracic circumference
0.056??????? 28 (70.0%) 12 (30.0%) 2.520
>92.42 25 (48.12%) 27 (81.9%) (1.058-6.002)
Table 7. Relationship between BMI, SCD, and thoracic circumference based on category 
towards the success of liver stiffness measurement using XL probe 
Variables XL probe OR p value
Succeed Not succeed
Body mass index 1.000
??????? 32 (88.9%)  4 (11.1%) 1.143
>30.85 49 (87.5%) (0.30-4.222)
Skin to liver capsule distance 0.527
?????? 29 (85.2%) 5 (14.7%) 0.669
>2.16 52 (89.7%) 6 (10.3%) (0.138-2.365)
Thoracic circumference 1.000
??????? 35 (87.5%) 5 (12.9%) 0.913
>92.42 46 (83.5%) 6 (11.5%) (0.258-3.237)
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the studies performed by Myers et al, Lesmana CA et 
al, and Wong et al.31,32,33
In this study, we found that BMI, SCD, and 
thoracic circumference factors were related with 
the success of liver stiffness measurement using M 
??????? ??????????????? ?????????? ????????????? ????????
with p value of 0.007, 0.001, and 0.001, respectively. 
These results were different with the study conducted 
by Ledinghen et al, in which only SCD and thoracic 
circumference were associated with the success of liver 
stiffness measurement using M probe.16 This could 
possibly be caused by the different obesity criteria 
being used in the study. In this study, we used the Asia 
????????????????? ????? ?????????????? ????????????2, 
while in the study performed by Ledinghen et al, they 
used WHO criteria, which was obesity if BMI > 30 kg/
m2. Therefore, the average value of BMI was higher, 
particularly 40.5 kg/m2. Similar with the study done by 
Foucher et al, in which the results were BMI factor > 
28 which was associated with failure of liver stiffness 
measurement with p value = 0,001.23 Different results 
were also found in the study conducted by Ledinghen et 
al, in which age and BMI > 30 were associated with the 
success of liver stiffness measurement using M probe 
and only BMI > 30 factor was associated the success of 
liver stiffness measurement using XL probe.20 Results 
???????????? ??????????????????????????????????????
and central obesity were factors associated with the 
failure of liver stiffness measurement. 33
In this study, it was revealed that BMI, SCD, and 
?????????????????????????????????????????????????????
associated with the success rate of liver stiffness 
measurement using XL probe with p value of 0.321, 
0.817 and 0.216, respectively. This was because in this 
study 88% patients (81 patients) succeed to undergo 
liver stiffness measurement using XL probe. Therefore, 
in this study, those factors could be overcome by XL 
probe. This condition showed that XL probe in this 
study was better in measuring liver stiffness compared 
to M probe in NAFLD patients with obesity. The results 
of this study were different from the study performed 
by Ledinghen et al.19 This study revealed that SCD 
factor was associated with the success rate of liver 
stiffness measurement using the XL probe. This could 
possibly be caused by the higher average value of SCD 
obtained in their study, which was 2.8 cm. From t-test 
statistical test as shown in Table 4, we found that the 
mean of thoracic circumference to whom liver stiffness 
measurement failed to be obtained using M probe was 
97.8 cm. Using the Mann-Whitney test, also as shown 
in Table 4, we found that the median value of BMI and 
SCD to whom liver stiffness measurement failed to be 
obtained using the M probe were 32.7 kg/m2 and 2.6 
cm, respectively. This was in concordance with the 
fact that liver stiffness measurement using M probe 
performed in patients with BMI with normal body 
weight and SCD < 2.5 cm and in SCD from 2.5-3.5 
were suggested to use the XL probe.
CONCLUSION
The success rate of liver stiffness measurement using 
???????????????????? ???????? ???????????????????????
????????????????????????????????????????????????????
success of liver stiffness measurement by using TE were 
BMI, SCD, and thoracic circumference. To increase 
the success of liver stiffness measurement, in NAFLD 
patients with obesity whose BMI, SCD, and thoracic 
circumference were more than 32.7 kg/m2, 2.6 cm and 
97.8 cm, it would be better to use the XL probe. The 
results of this study could be used as a baseline for 
further studies in larger research scale to determine 
the cut-off and predictor model towards factors which 
????????????????????????????????????????? ???????????
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